Download presentation
Presentation is loading. Please wait.
Published byΑντιγόνη Αρβανίτης Modified over 5 years ago
1
Patient disposition. *Patients who switched multiple times were not included in this analysis; **for patients switching treatment regimens, discontinuations from study within 30 days of treatment switch are reported; ***‘other reasons’ included patients lost to follow-up, patients no longer willing to participate, withdrawals due to pregnancy, protocol violations and study termination by sponsor. Patient disposition. *Patients who switched multiple times were not included in this analysis; **for patients switching treatment regimens, discontinuations from study within 30 days of treatment switch are reported; ***‘other reasons’ included patients lost to follow-up, patients no longer willing to participate, withdrawals due to pregnancy, protocol violations and study termination by sponsor. AE, adverse event; BID, twice daily; csDMARD, conventional synthetic disease-modifying antirheumatic drug; LTE, long-term extension. Roy Fleischmann et al. RMD Open 2017;3:e000491 Copyright © BMJ Publishing Group & EULAR. All rights reserved.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.